Elledge RM - Search Results

1

Elledge RM, McGuire WL, Osborne CK. Elledge RM, et al. Semin Oncol. 1992 Jun;19(3):244-53. Semin Oncol. 1992. PMID: 1351692 Review. No abstract available.

2

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.

Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL. Allred DC, et al. J Natl Cancer Inst. 1993 Feb 3;85(3):200-6. doi: 10.1093/jnci/85.3.200. J Natl Cancer Inst. 1993. PMID: 8423624

3

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.

Elledge RM, Clark GM, Chamness GC, Osborne CK. Elledge RM, et al. J Natl Cancer Inst. 1994 May 4;86(9):705-12. doi: 10.1093/jnci/86.9.705. J Natl Cancer Inst. 1994. PMID: 7908990

4

Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients.

Elledge RM, Ciocca DR, Langone G, McGuire WL. Elledge RM, et al. Cancer. 1993 Apr 15;71(8):2499-506. doi: 10.1002/1097-0142(19930415)71:8<2499::aid-cncr2820710812>3.0.co;2-s. Cancer. 1993. PMID: 8095853

5

The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain.

Fuqua SA, Allred DC, Elledge RM, Krieg SL, Benedix MG, Nawaz Z, O'Malley BW, Greene GL, McGuire WL. Fuqua SA, et al. Among authors: elledge rm. Breast Cancer Res Treat. 1993;26(2):191-202. doi: 10.1007/BF00689692. Breast Cancer Res Treat. 1993. PMID: 8219256

6

Prognostic significance of p53 gene alterations in node-negative breast cancer.

Elledge RM, Fuqua SA, Clark GM, Pujol P, Allred DC, McGuire WL. Elledge RM, et al. Breast Cancer Res Treat. 1993;26(3):225-35. doi: 10.1007/BF00665800. Breast Cancer Res Treat. 1993. PMID: 8251647

7

Prognostic factors and therapeutic decisions in axillary node-negative breast cancer.

Elledge RM, McGuire WL. Elledge RM, et al. Annu Rev Med. 1993;44:201-10. doi: 10.1146/annurev.me.44.020193.001221. Annu Rev Med. 1993. PMID: 8476242 Review.

8

bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study.

Elledge RM, Green S, Howes L, Clark GM, Berardo M, Allred DC, Pugh R, Ciocca D, Ravdin P, O'Sullivan J, Rivkin S, Martino S, Osborne CK. Elledge RM, et al. J Clin Oncol. 1997 May;15(5):1916-22. doi: 10.1200/JCO.1997.15.5.1916. J Clin Oncol. 1997. PMID: 9164202

9

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.

Elledge RM, Green S, Ciocca D, Pugh R, Allred DC, Clark GM, Hill J, Ravdin P, O'Sullivan J, Martino S, Osborne CK. Elledge RM, et al. Clin Cancer Res. 1998 Jan;4(1):7-12. Clin Cancer Res. 1998. PMID: 9516946

10

Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy.

Diab SG, Hilsenbeck SG, de Moor C, Clark GM, Osborne CK, Ravdin PM, Elledge RM. Diab SG, et al. Among authors: elledge rm. J Clin Oncol. 1998 May;16(5):1655-60. doi: 10.1200/JCO.1998.16.5.1655. J Clin Oncol. 1998. PMID: 9586875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters